Results 91 to 100 of about 191,956 (212)

AB₅-Type Toxin as a Pentameric Scaffold in Recombinant Vaccines against the Japanese Encephalitis Virus. [PDF]

Toxins (Basel), 2023
Ahn J, Yu JE, Kim H, Sung J, Han G, Sohn MH, Seong BL.   +6 more
europepmc   +1 more source

Recombinant vaccines in 2022: a perspective from the cell factory. [PDF]

Microb Cell Fact, 2022
de Pinho Favaro MT, Atienza-Garriga J, Martínez-Torró C, Parladé E, Vázquez E, Corchero JL, Ferrer-Miralles N, Villaverde A.   +7 more
europepmc   +1 more source

Modified dipeptide based nanospheres as a potent adjuvating delivery system for recombinant vaccines. [PDF]

Front Drug Deliv, 2023
Biswas S, Yadav N, Somanathan A, Mukherjee P, Chauhan VS.   +4 more
europepmc   +1 more source

New recombinant rabies vaccines

Биопрепараты: Профилактика, диагностика, лечение, 2018
The review covers problems of construction and production of new recombinant rabies vaccine. New approaches are being investigated to develop rabies vaccine and include methods of reverse genetic, production of virus antigens in plant cells cultures ...
E. S. Sedova, M. M. Shmarov
doaj  

Advances in Pasteurella multocida Vaccine Development: From Conventional to Next-Generation Strategies

Vaccines
Pasteurella multocida is a Gram-negative bacterium causing significant livestock diseases, like fowl cholera and hemorrhagic septicemia in cattle, and wound infection in humans.
Adehanom Baraki Tesfaye, Geberemeskel Mamu Werid, Zhengyu Tao, Liuchao You, Rui Han, Jiayao Zhu, Lei Fu, Yuefeng Chu   +7 more
doaj   +1 more source

Comparison of Current Regulatory Status for Gene-Based Vaccines in the U.S., Europe and Japan

Vaccines, 2015
Gene-based vaccines as typified by plasmid DNA vaccines and recombinant viral-vectored vaccines are expected as promising solutions against infectious diseases for which no effective prophylactic vaccines exist such as HIV, dengue virus, Ebola virus and
Yoshikazu Nakayama, Atsushi Aruga
doaj   +1 more source

Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines. [PDF]

NPJ Vaccines, 2022
Ebenig A, Lange MV, Mühlebach MD.
europepmc   +1 more source

Recombinant viral vaccines for cancer

Trends in Molecular Medicine, 2012
Cancer arises from 'self' in a series of steps that are all subject to immunoediting. Therefore, therapeutic cancer vaccines must stimulate an immune response against tumour antigens that have already evaded the body's immune defences. Vaccines presenting a tumour antigen in the context of obvious danger signals seem more likely to stimulate a response.
Cawood, R, Hills, T, Wong, S, Alamoudi, A, Beadle, S, Fisher, K, Seymour, L   +6 more
openaire   +3 more sources

Challenges and Strategies for Developing Recombinant Vaccines against Leptospirosis: Role of Expression Platforms and Adjuvants in Achieving Protective Efficacy. [PDF]

Pathogens, 2023
de Oliveira NR, Santos FDS, Dos Santos VAC, Maia MAC, Oliveira TL, Dellagostin OA.   +5 more
europepmc   +1 more source

Plant-Derived Recombinant Vaccines against Zoonotic Viruses. [PDF]

Life (Basel), 2022
Zahmanova G, Takova K, Valkova R, Toneva V, Minkov I, Andonov A, Lukov GL.   +6 more
europepmc   +1 more source